Tag: 2026
Health Ministry Amends Drugs Rules to Ban Misleading and Fake Documentation
The Union Ministry of Health and Family Welfare has officially issued the Drugs (Eleventh Amendment) Rules, 2026, introducing strict regulatory provisions to debar applicants...
Dr. Reddy’s Strengthens U.S. Portfolio with First Generic Sugammadex Injection Launch
Dr. Reddy’s Laboratories Ltd. has introduced SugammadexInjection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) single-dose vials, a generic equivalent of Merck's Bridion®,...
Pathos AI Expands Oncology Pipeline Through Strategic Deals with Alphamab and AstraZeneca
Pathos AI announced two separate licensing and co-development agreements with Alphamab Oncology and AstraZeneca, expanding its clinical-stage pipeline of targeted cancer therapies using its proprietary platform,...
FSSAI Directs Dabur to Withdraw Some Food Products Carrying ‘100%’ Claims
The Food Safety and Standards Authority of India (FSSAI) has intensified its scrutiny of misleading food advertisements, particularly the use of absolute claims such...
Ayushman Bharat Hits 12.69 Crore Hospital Admissions, Reducing Healthcare Burden on Families
India's flagship health insurance programme, Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), has facilitated 12.69 crore cashless hospitalisations valued at ₹1.92 lakh crore as of June 30, 2026, according to...
AMTZ and IIT Delhi’s IHFC Partner to Launch Medical Robotics Initiative
In a significant step towards advancing medical robotics in India, the Technology Innovation Hub Foundation for IoT and IoE (IHFC) at IIT Delhi and...
